AXLA RSI Chart
Last 7 days
-20%
Last 30 days
-87.5%
Last 90 days
-96.2%
Trailing 12 Months
-94.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 |
2022 | 260.7K | 382.3K | 0 | 504.0K |
2021 | 250.3K | 194.7K | 0 | 139.0K |
2020 | 1.3M | 808.7K | 0 | 306.0K |
2019 | 1.2M | 0 | 0 | 1.8M |
2018 | 0 | 0 | 0 | 547.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2023 | koziel margaret | sold | -393 | 0.58 | -679 | chief medical officer |
Feb 10, 2023 | fehlner paul | acquired | 3,446 | 0.6602 | 5,221 | svp & chief legal officer |
Oct 19, 2022 | hinshaw william | sold | -25,027 | 1.5642 | -16,000 | president & ceo |
Oct 17, 2022 | hinshaw william | acquired | - | - | 50,000 | president & ceo |
Oct 13, 2022 | societe des produits nestle s.a. | bought | 6,000,010 | 1.64 | 3,658,540 | - |
Oct 13, 2022 | flagship ventures fund iv general partner llc | bought | 5,000,000 | 1.64 | 3,048,780 | - |
Oct 13, 2022 | flagship ventures fund iv general partner llc | bought | 9,022,020 | 1.64 | 5,501,230 | - |
Oct 13, 2022 | flagship ventures fund iv general partner llc | bought | 3,007,340 | 1.64 | 1,833,740 | - |
Sep 06, 2022 | koziel margaret | sold | -1,378 | 2.5195 | -547 | chief medical officer |
Jun 01, 2022 | koziel margaret | sold | -1,186 | 2.0107 | -590 | chief medical officer |
Which funds bought or sold AXLA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Lindbrook Capital, LLC | unchanged | - | -32.00 | - | -% |
Jul 15, 2022 | Pinnacle Private Wealth, LLC | added | 108 | 49,000 | 125,000 | 0.05% |
Jul 28, 2021 | Hoover Financial Advisors, Inc. | sold off | -100 | -3,000 | - | -% |
Unveiling Axcella Health Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Axcella Health Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Axcella Health Inc News
Income Statement (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q1 | 2018Q4 |
Revenue | -5.7% | 132 | 140 | 103 | 65.00 | 22.00 | 35.00 | 48.00 | 35.00 | 27.00 | 18.00 | 257 | 324 | 390 | - |
Operating Expenses | -15.3% | 3,543 | 4,183 | 20,946 | 20,619 | 18,330 | 17,203 | 15,244 | 14,496 | 14,467 | 13,184 | 14,460 | 15,340 | 11,031 | 9,163 |
S&GA Expenses | -15.7% | 2,319 | 2,750 | 3,500 | 3,753 | 4,786 | 4,736 | 4,946 | 4,256 | 3,869 | 4,619 | 4,125 | 2,745 | 3,468 | 1,286 |
R&D Expenses | -14.6% | 1,224 | 1,433 | 13,257 | 16,866 | 13,544 | 12,467 | 10,298 | 10,240 | 10,598 | 8,565 | 10,335 | 12,595 | 7,563 | 7,877 |
Interest Expenses | - | - | - | 1,146 | 627 | 573 | 1,190 | 571 | 566 | 1,875 | -708 | 669 | 3,326 | 881 | 4,405 |
Net Income | 14.2% | -3,413 | -3,976 | -23,000 | -21,306 | -19,039 | -17,891 | -15,935 | -15,189 | -15,189 | -13,892 | -15,009 | -15,713 | -11,573 | -9,762 |
Net Income Margin | 27.1% | -95.69* | -131.20* | -161.08* | -193.15* | -262.70* | -464.95* | -301.80* | -226.53* | -184.73* | -76.57* | - | - | - | - |
Free Cashflow | -72.5% | -8,800 | -5,100 | -15,569 | -35,538 | -17,026 | -13,637 | -14,468 | -14,195 | -10,243 | -12,577 | - | - | - | - |
Balance Sheet | ||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -27.3% | 9.00 | 13.00 | 19.00 | 31.00 | 50.00 | 68.00 | 58.00 | 69.00 | 81.00 | 94.00 | 110 | 120 | 125 | 78.00 | 94.00 | 109 | 122 | 71.00 | 82.00 |
Current Assets | -27.3% | 9.00 | 13.00 | 18.00 | 27.00 | 46.00 | 64.00 | 57.00 | 68.00 | 80.00 | 94.00 | 109 | 120 | 124 | 77.00 | 94.00 | 108 | 121 | 68.00 | 80.00 |
Cash Equivalents | -29.0% | 9.00 | 13.00 | 17.00 | 25.00 | 34.00 | 45.00 | 24.00 | 26.00 | 34.00 | 43.00 | 72.00 | 114 | 121 | 76.00 | 92.00 | 105 | 118 | 67.00 | 79.00 |
Net PPE | -40.0% | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -4.1% | 12.00 | 12.00 | 15.00 | 38.00 | 41.00 | 38.00 | 36.00 | 33.00 | 33.00 | 33.00 | 34.00 | 31.00 | 32.00 | 31.00 | 34.00 | 35.00 | 32.00 | 33.00 | 34.00 |
Current Liabilities | -3.0% | 12.00 | 12.00 | 14.00 | 22.00 | 17.00 | 13.00 | 10.00 | 8.00 | 12.00 | 10.00 | 8.00 | 5.00 | 11.00 | 7.00 | 8.00 | 9.00 | 7.00 | 6.00 | 7.00 |
Long Term Debt | - | - | - | - | 15.00 | 22.00 | 23.00 | 25.00 | 25.00 | 20.00 | 21.00 | 25.00 | 25.00 | 20.00 | 23.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
LT Debt, Current | - | - | - | - | 6.00 | 3.00 | 2.00 | - | - | 6.00 | 4.00 | - | - | 5.00 | 2.00 | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | 15.00 | 22.00 | 23.00 | 25.00 | 25.00 | 20.00 | 21.00 | 25.00 | - | - | - | - | - | - | - | - |
Shareholder's Equity | -100.0% | - | 1.00 | 4.00 | - | 9.00 | 30.00 | 22.00 | 36.00 | 48.00 | 62.00 | 75.00 | 89.00 | 93.00 | 47.00 | 60.00 | 74.00 | 90.00 | - | - |
Retained Earnings | -0.8% | -425 | -422 | -418 | -395 | -377 | -356 | -337 | -319 | -303 | -287 | -272 | -257 | -244 | -231 | -216 | -200 | -183 | -168 | -157 |
Additional Paid-In Capital | 0.1% | 423 | 423 | 423 | 388 | 387 | 386 | 359 | 355 | 352 | 349 | 348 | 346 | 338 | 278 | 276 | 275 | 273 | 8.00 | 7.00 |
Shares Outstanding | 0.0% | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | - | - | - | - | - | - |
Float | - | - | - | - | - | 68.00 | - | - | - | 101 | - | - | - | 107 | - | - | - | 107 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -72.5% | -8,800 | -5,100 | -15,550 | -10,104 | -35,500 | -16,862 | -13,637 | -12,217 | -14,222 | -14,145 | -10,063 | -10,659 | -12,518 | -16,531 | -13,381 | -12,134 | -13,250 | -12,197 | -7,570 | -7,476 | -7,541 |
Share Based Compensation | -20.6% | 428 | 539 | 530 | 950 | 594 | 1,509 | 1,471 | 1,667 | 1,677 | 1,428 | 1,360 | 1,372 | 1,956 | 1,599 | 1,502 | 1,678 | 1,507 | 1,137 | 881 | 819 | 710 |
Cashflow From Investing | -100.0% | - | 525 | -19.00 | 10,170 | 7,612 | 13,160 | 8,230 | 4,771 | 4,438 | -14,392 | -32,864 | -3,196 | -59.00 | - | -34.00 | -36.00 | - | -47.00 | -173 | - | -125 |
Cashflow From Financing | 100.0% | - | -27.00 | 7,279 | -301 | -58.00 | 25,318 | 2,890 | -403 | 675 | -4.00 | 454 | 6,592 | 58,381 | - | 113 | -385 | 64,391 | -453 | 63,764 | 27.00 | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Operating expenses: | ||||
Research and development | $ 1,224 | $ 16,866 | $ 2,657 | $ 30,410 |
General and administrative | 2,319 | 3,753 | 5,069 | 8,539 |
Total operating expenses | 3,543 | 20,619 | 7,726 | 38,949 |
Loss from operations | (3,543) | (20,619) | (7,726) | (38,949) |
Other (expense) income: | ||||
Interest income | 132 | 65 | 272 | 87 |
Interest expense | 0 | (752) | 0 | (1,456) |
Other income (expense), net | (2) | 0 | 65 | (27) |
Total other income (expense), net | 130 | (687) | 337 | (1,396) |
Net loss | $ (3,413) | $ (21,306) | $ (7,389) | $ (40,345) |
Net loss per share, basic (USD per share) | $ (0.05) | $ (0.40) | $ (0.10) | $ (0.86) |
Net loss per share, diluted (USD per share) | $ (0.05) | $ (0.40) | $ (0.10) | $ (0.86) |
Weighted average common shares outstanding, basic (in shares) | 73,688,558 | 52,616,279 | 73,678,881 | 47,052,105 |
Weighted average common shares outstanding, diluted (in shares) | 73,688,558 | 52,616,279 | 73,678,881 | 47,052,105 |
Comprehensive loss: | ||||
Net loss | $ (3,413) | $ (21,306) | $ (7,389) | $ (40,345) |
Other comprehensive income (loss): | ||||
Unrealized losses on marketable securities | 0 | 4 | 0 | (14) |
Comprehensive loss | $ (3,413) | $ (21,302) | $ (7,389) | $ (40,359) |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 8,884 | $ 17,147 |
Prepaid expenses and other current assets | 383 | 876 |
Total current assets | 9,267 | 18,023 |
Property and equipment, net | 15 | 693 |
Other assets | 0 | 211 |
Total assets | 9,282 | 18,927 |
Current liabilities: | ||
Accounts payable | 8,395 | 4,707 |
Accrued expenses and other current liabilities | 1,754 | 7,849 |
Current portion of operating lease liability | 1,391 | 1,592 |
Total current liabilities | 11,540 | 14,148 |
Operating lease liability | 0 | 569 |
Other non-current liabilities | 0 | 46 |
Total liabilities | 11,540 | 14,763 |
Commitments and contingencies (Note 8) | 0 | 0 |
Stockholders' equity (deficit): | ||
Common stock, $0.001 par value; 150,000,000 shares authorized, 74,111,726 and 74,074,201 shares issued and 73,692,745 and 73,655,220 shares outstanding at June 30, 2023 and December 31, 2022, respectively | 74 | 74 |
Additional paid-in capital | 423,484 | 422,517 |
Treasury stock, 418,981 shares at cost | 0 | 0 |
Accumulated deficit | (425,816) | (418,427) |
Total stockholders' equity (deficit) | (2,258) | 4,164 |
Total liabilities and stockholders' equity (deficit) | $ 9,282 | $ 18,927 |